• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞 C1 型上 MHC Ⅱ类分子的缺失引发对交叉呈递自身抗原的致命自身免疫。

Absence of MHC class II on cDC1 dendritic cells triggers fatal autoimmunity to a cross-presented self-antigen.

机构信息

Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, 13288 Marseille, France.

Centre d'Immunophénomique, Aix Marseille Université, INSERM, CNRS, 13288 Marseille, France.

出版信息

Sci Immunol. 2020 Mar 13;5(45). doi: 10.1126/sciimmunol.aba1896.

DOI:10.1126/sciimmunol.aba1896
PMID:32169954
Abstract

Conventional dendritic cells expressing the XCR1 chemokine receptor (cDC1s) excel at cross-presentation. Here, we developed and used a mouse model in which a Cre recombinase is expressed under the control of the gene while preserving XCR1 expression. We used it to generate mice with conditional deletion of MHC class II (MHCII) molecules on cDC1s. By preventing cDC1s to receive suppressive regulatory T cell inputs via MHCII-restricted interactions, the objective of the present study was to gauge whether MHCII-deficient cDC1s lose their capacity of tolerizing autoreactive CD8 T cells. Whereas MHCII cDC1 readily cross-tolerized strongly autoreactive CD8 T cells specific for a keratinocyte-derived self-antigen, MHCII-deficient cDC1s converted them into potent effectors capable of triggering a fast-onset lethal autoimmunity associated with severe skin histopathological manifestations. Preventing egress of such pathogenic self-reactive CD8 T cell effectors from the cutaneous draining lymph nodes abrogated the autoimmune condition. Therefore, our results revealed that the cross-tolerizing capacity of cDC1s is not a property fully acquired at the time they undergo homeostatic maturation but needs to be enforced via MHCII-restricted, suppressive interactions with regulatory T cells.

摘要

表达 XCR1 趋化因子受体(cDC1s)的常规树突状细胞擅长交叉呈递。在这里,我们开发并使用了一种小鼠模型,其中 Cre 重组酶在 基因的控制下表达,同时保留 XCR1 的表达。我们用它来生成 cDC1s 上 MHC II 类分子(MHCII)条件性缺失的小鼠。通过防止 cDC1s 通过 MHCII 限制的相互作用接收抑制性调节性 T 细胞的输入,本研究的目的是评估 MHCII 缺陷的 cDC1s 是否丧失耐受自身反应性 CD8 T 细胞的能力。虽然 MHCII cDC1 很容易交叉耐受对角质细胞衍生的自身抗原具有强烈自身反应性的 CD8 T 细胞,但 MHCII 缺陷的 cDC1 将它们转化为能够触发快速发作的致命自身免疫的有效效应物,伴有严重的皮肤组织病理学表现。阻止这些致病性自身反应性 CD8 T 细胞效应物从皮肤引流淋巴结中逸出可消除自身免疫状态。因此,我们的结果表明,cDC1 的交叉耐受能力不是它们经历稳态成熟时完全获得的特性,而是需要通过 MHCII 限制的、与调节性 T 细胞的抑制性相互作用来加强。

相似文献

1
Absence of MHC class II on cDC1 dendritic cells triggers fatal autoimmunity to a cross-presented self-antigen.树突状细胞 C1 型上 MHC Ⅱ类分子的缺失引发对交叉呈递自身抗原的致命自身免疫。
Sci Immunol. 2020 Mar 13;5(45). doi: 10.1126/sciimmunol.aba1896.
2
cDC1 prime and are licensed by CD4 T cells to induce anti-tumour immunity.cDC1 呈递抗原并被 CD4 T 细胞许可,以诱导抗肿瘤免疫。
Nature. 2020 Aug;584(7822):624-629. doi: 10.1038/s41586-020-2611-3. Epub 2020 Aug 12.
3
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.携带死肿瘤抗原的天然小鼠常规型 1 树突状细胞的有效癌症免疫疗法。
J Immunother Cancer. 2019 Apr 8;7(1):100. doi: 10.1186/s40425-019-0565-5.
4
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.通过淋巴细胞趋化因子将NY-ESO-1肿瘤抗原有效靶向至人cDC1可导致交叉呈递和抗原特异性T细胞扩增。
J Immunother Cancer. 2022 Apr;10(4). doi: 10.1136/jitc-2021-004309.
5
Novel Cre-Expressing Mouse Strains Permitting to Selectively Track and Edit Type 1 Conventional Dendritic Cells Facilitate Disentangling Their Complexity .新型 Cre 表达小鼠品系可选择性追踪和编辑 1 型传统树突状细胞,有助于厘清其复杂性。
Front Immunol. 2018 Dec 4;9:2805. doi: 10.3389/fimmu.2018.02805. eCollection 2018.
6
Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.抗原交叉呈递和 T 细胞交叉呈递在癌症免疫和免疫治疗中的作用。
Ann Oncol. 2017 Dec 1;28(suppl_12):xii44-xii55. doi: 10.1093/annonc/mdx237.
7
MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity.浆细胞样树突状细胞 MHC II 类限制性抗原提呈抑制 T 细胞介导的自身免疫。
J Exp Med. 2010 Aug 30;207(9):1891-905. doi: 10.1084/jem.20092627. Epub 2010 Aug 9.
8
Mast cells acquire MHCII from dendritic cells during skin inflammation.在皮肤炎症期间,肥大细胞从树突状细胞获得主要组织相容性复合体II类分子。
J Exp Med. 2017 Dec 4;214(12):3791-3811. doi: 10.1084/jem.20160783. Epub 2017 Oct 30.
9
Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles.前沿:树突状细胞亚群在 MHC Ⅱ类相关病毒粒子呈递中的有限特化。
J Immunol. 2010 Jan 1;184(1):26-9. doi: 10.4049/jimmunol.0901540. Epub 2009 Nov 30.
10
A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8 T Cells.XCL1/Lymphotactin 的一种高活性形式可作为有效的佐剂,募集表达交叉呈递的树突状细胞,诱导效应和记忆性 CD8 T 细胞。
Front Immunol. 2018 Nov 27;9:2775. doi: 10.3389/fimmu.2018.02775. eCollection 2018.

引用本文的文献

1
Xcr1 type 1 conventional dendritic cells are essential mediators for atherosclerosis progression.Xcr1 1型传统树突状细胞是动脉粥样硬化进展的重要介质。
Elife. 2025 Sep 11;14:RP107742. doi: 10.7554/eLife.107742.
2
Targeting Langerhans cells via skin delivery of HIV Envelope enhances the antibody response to vaccination.通过皮肤递送HIV包膜靶向朗格汉斯细胞可增强疫苗接种的抗体反应。
NPJ Vaccines. 2025 Jul 25;10(1):170. doi: 10.1038/s41541-025-01214-w.
3
cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy.
浆细胞样树突状细胞1通过局部免疫促进动脉粥样硬化,且是可靶向治疗的。
Circ Res. 2025 Jul 18;137(3):400-416. doi: 10.1161/CIRCRESAHA.124.325792. Epub 2025 May 30.
4
A coordinated cellular network regulates tolerance to food.一个协调的细胞网络调节对食物的耐受性。
Nature. 2025 May 27. doi: 10.1038/s41586-025-09173-x.
5
Suppression of melanoma by mice lacking MHC-II: Mechanisms and implications for cancer immunotherapy.MHC-II 缺失的小鼠对黑色素瘤的抑制作用:机制及其对癌症免疫治疗的意义。
J Exp Med. 2024 Dec 2;221(12). doi: 10.1084/jem.20240797. Epub 2024 Oct 29.
6
Striking a balance: new perspectives on homeostatic dendritic cell maturation.寻求平衡:稳态树突状细胞成熟的新视角
Nat Rev Immunol. 2025 Feb;25(2):125-140. doi: 10.1038/s41577-024-01079-5. Epub 2024 Sep 17.
7
The CD8 T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects.CD8 T 细胞耐受检查点触发由蛋白质翻译缺陷定义的独特分化状态。
Immunity. 2024 Jun 11;57(6):1324-1344.e8. doi: 10.1016/j.immuni.2024.04.026. Epub 2024 May 21.
8
Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses.Bcl6 基因缺失对常规树突状细胞亚群有差异影响,并损害了 Tfh/Tfr/Th17 细胞应答。
Nat Commun. 2024 Apr 30;15(1):3554. doi: 10.1038/s41467-024-46966-6.
9
Concise review: The heterogenous roles of BATF3 in cancer oncogenesis and dendritic cells and T cells differentiation and function considering the importance of BATF3-dependent dendritic cells.简明回顾:考虑到依赖 BATF3 的树突状细胞的重要性,BATF3 在癌症发生和树突状细胞与 T 细胞分化和功能中的异质作用。
Immunogenetics. 2024 Apr;76(2):75-91. doi: 10.1007/s00251-024-01335-x. Epub 2024 Feb 15.
10
Segmented filamentous bacteria-induced epithelial MHCII regulates cognate CD4+ IELs and epithelial turnover.分段丝状菌诱导的上皮 MHCII 调节同源 CD4+ IELs 和上皮细胞更新。
J Exp Med. 2024 Jan 1;221(1). doi: 10.1084/jem.20230194. Epub 2023 Oct 30.